http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-202192092-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-202192092-A3 |
| titleOfInvention | TETRAHYDRO-PYRIDO[3,4-B]INDOL MODULATORS OF ESTROGEN RECEPTORS AND THEIR APPLICATION |
| abstract | The invention describes compounds of tetrahydropyrido[3,4-b]indol-1-yl with modulating activity or function of the estrogen receptor, having the structure of formula I and their stereoisomers, tautomers or pharmaceutically acceptable salts, and with substituents and structural features described in this document . Also described are pharmaceutical compositions and medicaments that include compounds of formula I, as well as methods of using such estrogen receptor modulators alone and in combination with other therapeutic agents for the treatment of diseases or conditions mediated or dependent on estrogen receptors. |
| priorityDate | 2015-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407944694 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107838 |
Total number of triples: 16.